查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087611

轉錄組學技術市場：按技術類型、實驗方法、解析度等級、資料輸出格式和應用分類的全球市場預測 – 2026-2032 年

Transcriptomics Technologies Market by Technology Type, Experimental Method, Resolution Level, Data Output Type, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，轉錄組學技術市場將成長至 119.3 億美元，複合年成長率為 5.15%。

主要市場統計數據
基準年 2025 83.9億美元
預計年份：2026年 87.9億美元
預測年份 2032 119.3億美元
複合年成長率 (%) 5.15%

轉錄組學技術能夠捕捉RNA表現、異構體多樣性、基因調控和細胞狀態，在現代基因組學、精準醫學、藥物發現、生物標記開發和轉化研究中發揮核心作用。該領域得到了多種技術的支持，包括批量RNA定序、單細胞RNA定序、單核RNA定序、空間轉錄組學、微陣列、基於qPCR的表達譜分析和長讀長RNA定序，每種技術都為獨特的科學研究和臨床工作流程做出了貢獻。

隨著製藥公司、大學附屬醫院、受託研究機構和診斷公司利用轉錄組數據闡明疾病機制、對患者進行分層、監測治療反應以及識別可操作的訊號通路，對轉錄組數據的需求日益成長。諸如NCBI的基因表現綜合資料庫（GEO）、序列讀取檔案庫（SRA）和歐洲核苷酸資料庫（ENA）等公共資料庫不斷擴充轉錄組資料集，反映出基於RNA的研究在腫瘤學、免疫學、神經科學、感染疾病、生殖健康和農業生物技術等領域的規模日益擴大。

轉錄組學領域的變革性變化

轉錄組學領域正從單一的基因表現檢測轉向整合的多體學、高空間解析度、人工智慧驅動的生物學解讀。雖然批量RNA定序仍然是一種經濟高效的發現工具，但單細胞和單核分析方法正在顯著提高複雜組織中細胞類型的解析度，尤其是在癌症、神經科學、自體免疫疾病和發育生物學領域。

人工智慧的累積影響

人工智慧透過改善數據標準化、細胞註釋、批次校正、軌跡推斷、空間反捲積、生物標記優先排序和藥物標靶發現，進一步提升了轉錄組學的價值。機器學習和深度學習模型尤其適用於從高維RNA定序資料中提取僅靠傳統統計方法難以檢測到的模式。

主要區域趨勢

隨著中國、日本、印度、韓國和澳洲等國加大對基因組學基礎設施、學術定序中心、生物製藥研發以及人群規模生物醫學舉措的投資，亞太地區正迅速擴張。癌症基因組學計畫、感染疾病監測、老化相關研究以及農業生物技術應用是推動這項擴張的主要動力。北美憑藉其雄厚的公共生物醫學資金、大型生物技術叢集、先進的定序技術應用以及由設備供應商、雲端服務提供商、受託研究機構（CRO）、臨床檢查室和精準醫療項目組成的密集生態系統，繼續保持全球領先地位。

關鍵小組洞察

在東協地區，由於新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國生物醫學研究的蓬勃發展，轉錄組學的重要性日益凸顯。區域疾病監測、癌症研究、人口健康調查和農業生物技術的發展也為此提供了支持。隨著海灣合作理事會（GCC）成員國將基因組學作為醫療衛生現代化進程中的優先事項，轉錄組學在支持罕見疾病研究、癌症譜分析、遺傳疾病研究以及國家級人口健康舉措具有得天獨厚的優勢。

主要國家的概況

美國憑藉生物技術叢集、大​​學附屬醫療中心、製藥公司研發、國家生物醫學研究經費、臨床基因組學計畫以及成熟的創業投資環境，在轉錄組學商業化方面處於領先地位。同時，加拿大透過國家網路、人口健康舉措和精準醫療項目，大力支持基因組學研究。墨西哥和巴西正在拓展其在腫瘤學、感染疾病和農業生物技術領域的能力，其中巴西受益於其大規模的生物醫學研究基礎、公共衛生研究能力以及生物多樣性支持的應用技術。

為行業領導者提供的實用建議

產業領導者應優先考慮能夠將樣本製備、定序、生物資訊學和結果解讀整合到一個可重複且可審計的工作流程中的平台。投資決策應優先考慮能夠提高靈敏度、通量、空間解析度、異構體檢測以及與劣化或低起始量樣本（特別是轉化腫瘤學和病理學相關研究中使用的福馬林固定石蠟包埋組織）相容性的技術。

調查方法

本調查方法採用三角測量法，結契約儕審查的科學文獻、公共基因組資料儲存庫、臨床試驗註冊資訊、監管指南、資助公告、專利趨勢、公共衛生資源和技術採納指標。分析重點在於來自權威科學機構、監管機構和權威資訊來源的檢驗證據，而非未經證實的商業性聲明。

結論

轉錄組學技術正從探索性研究工具轉變為精準醫療、藥物發現、分子診斷和生物系統分析的基礎架構。這一趨勢的驅動力來自定序門檻的降低、單細胞和空間分析技術的廣泛應用、長讀長RNA分析技術的改進、雲生物資訊學的增強以及對具有臨床意義的RNA生物標記的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：轉錄組學技術市場：依技術類型分類

  • 批量轉錄組學
  • 單細胞轉錄組學
  • 空間轉錄組學
  • 具有空間解析度的單細胞技術

第8章：轉錄組學技術市場：依實驗方法分類

  • 基於定序的技術
  • 基於探針的技術
  • 基於成像的技術
  • 基於陣列的技術

第9章：轉錄組學技術市場：依解析度層級分類

  • 批量解析度
  • 單細胞解析度
  • 亞細胞解析度

第10章：轉錄組學技術市場：依資料輸出類型分類

  • 全轉錄組分析
  • 標靶轉錄組學
  • 多體學整合轉錄組學

第11章 轉錄組學技術市場：依應用領域分類

  • 腫瘤學
  • 神經病學
  • 免疫學
  • 發育生物學
  • 藥物發現

第12章 轉錄組學技術市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 轉錄組學技術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 轉錄組學技術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Dovetail Genomics
  • F. Hoffmann-La Roche Ltd.
  • Genomics England ecosystem partners
  • Illumina, Inc.
  • Mission Bio Inc.
  • NanoString Technologies
  • Novogene Corporation
  • Oxford Nanopore Technologies plc
  • Pacific Biosciences of California, Inc.
  • Parse Biosciences
  • QIAGEN NV
  • SeqWell Inc.
  • Singleron Biotechnologies
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue Inc.
  • Vizgen Inc.
Product Code: MRR-031685195774

The Transcriptomics Technologies Market is projected to grow by USD 11.93 billion at a CAGR of 5.15% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.39 billion
Estimated Year [2026] USD 8.79 billion
Forecast Year [2032] USD 11.93 billion
CAGR (%) 5.15%

Transcriptomics technologies capture RNA expression, isoform diversity, gene regulation, and cellular state, making them central to modern genomics, precision medicine, drug discovery, biomarker development, and translational research. The field is anchored by bulk RNA sequencing, single-cell RNA sequencing, single-nucleus RNA sequencing, spatial transcriptomics, microarrays, qPCR-based expression profiling, and long-read RNA sequencing, each serving distinct research and clinical workflows.

Demand is rising as pharmaceutical sponsors, academic medical centers, contract research organizations, and diagnostic developers use transcriptome data to understand disease mechanisms, stratify patients, monitor therapeutic response, and identify actionable pathways. Public repositories such as the NCBI Gene Expression Omnibus, Sequence Read Archive, and European Nucleotide Archive continue to expand with transcriptomic datasets, reflecting the growing scale of RNA-based research across oncology, immunology, neuroscience, infectious disease, reproductive health, and agricultural biotechnology.

Transformative Shifts in the Transcriptomics Landscape

The transcriptomics landscape is shifting from single-assay gene expression measurement toward integrated, multi-omic, spatially resolved, and AI-supported biological interpretation. Bulk RNA sequencing remains a cost-effective discovery tool, while single-cell and single-nucleus methods are transforming cell-type resolution in complex tissues, particularly in cancer, brain science, autoimmune disease, and developmental biology.

Spatial transcriptomics is one of the most important accelerators because it preserves tissue architecture while mapping gene expression, supporting pathology-adjacent research and translational oncology. At the same time, automation, unique molecular identifiers, improved sample preparation, cloud bioinformatics, and standardized quality-control metrics are reducing technical variability and improving scalability for regulated and high-throughput environments.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of transcriptomics by improving data normalization, cell annotation, batch correction, trajectory inference, spatial deconvolution, biomarker prioritization, and drug target discovery. Machine learning and deep learning models are especially useful for extracting patterns from high-dimensional RNA sequencing data that are difficult to detect with conventional statistics alone.

The cumulative impact of AI is most visible when transcriptomics is integrated with genomics, proteomics, epigenomics, imaging, clinical records, and real-world evidence. However, industry leaders must manage model bias, explainability, data provenance, privacy protection, and reproducibility. AI-enabled transcriptomics will create the greatest value where curated datasets, transparent pipelines, and clinically interpretable outputs are aligned with regulatory expectations and documented quality standards.

Key Regional Insights

Asia-Pacific is expanding rapidly as China, Japan, India, South Korea, and Australia invest in genomics infrastructure, academic sequencing centers, biopharmaceutical R&D, and population-scale biomedical initiatives. Regional adoption is supported by cancer genomics programs, infectious disease surveillance, aging-related research, and agriculture biotechnology applications. North America remains a global leader due to strong public biomedical funding, major biotechnology clusters, advanced sequencing adoption, and a dense ecosystem of instrument suppliers, cloud providers, contract research organizations, clinical laboratories, and precision medicine programs.

Europe benefits from coordinated research frameworks, biobanks, national health systems, and regulatory emphasis on data protection, reproducibility, and clinical evidence, with transcriptomics increasingly applied in oncology, rare disease, immunology, and population health research. Latin America is gaining momentum through infectious disease research, oncology collaborations, and expanding university-based sequencing capacity, especially in Brazil and Mexico. The Middle East is increasing investment in genomics-led healthcare and national precision medicine programs, particularly in Gulf markets, where rare disease, inherited disorder, and cancer initiatives are relevant. Africa is strengthening transcriptomics capabilities through infectious disease research, pathogen surveillance, population genetics, and international research partnerships that improve local sequencing, bioinformatics, and sample-to-data workflows.

Key Group Insights

ASEAN is becoming more relevant for transcriptomics through biomedical research growth in Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines, supported by regional disease surveillance, cancer research, population health studies, and agricultural biotechnology. The GCC is prioritizing genomics as part of healthcare modernization, with transcriptomics positioned to support rare disease research, cancer profiling, inherited disease investigation, and national population health initiatives.

The European Union supports transcriptomics through collaborative research funding, harmonized clinical research networks, cross-border biobanking, and strict data-governance requirements under GDPR, strengthening demand for secure and reproducible data pipelines. BRICS economies contribute scale through large patient populations, expanding pharmaceutical services, biomanufacturing capacity, infectious disease research, and national genomics programs, while the G7 leads in advanced sequencing infrastructure, AI-enabled life sciences, regulatory science, and clinical translation. NATO-aligned countries also support biosecurity, pathogen monitoring, health security, and defense-adjacent biotechnology capabilities that can include transcriptomic surveillance and rapid-response molecular research.

Key Country Insights

The United States leads transcriptomics commercialization through biotechnology clusters, academic medical centers, pharmaceutical R&D, national biomedical research funding, clinical genomics programs, and a mature venture capital environment, while Canada supports strong genomics research through national networks, population health initiatives, and precision health programs. Mexico and Brazil are expanding capabilities in oncology, infectious disease, and agricultural biotechnology, with Brazil benefiting from a large biomedical research base, public health research capacity, and biodiversity-driven applications.

In Europe, the United Kingdom, Germany, and France are major centers for genomics research, clinical trials, biobanking, molecular pathology, and translational medicine, while Italy and Spain contribute through hospital-based research, oncology networks, and EU-supported life science programs. Russia maintains scientific capability in molecular biology and bioinformatics, though international collaboration dynamics can affect access to advanced technologies, reagents, and commercialization pathways.

China is a scale leader in sequencing, clinical research, and biomanufacturing, supported by major investment in genomics infrastructure and precision medicine. India is rapidly expanding genomics adoption across healthcare, pharmaceutical services, bioinformatics, and infectious disease research. Japan emphasizes high-quality clinical research, aging-related disease studies, regenerative medicine, and oncology applications. Australia contributes through population health, cancer genomics, rare disease programs, and research consortia, and South Korea is advancing precision medicine through strong digital health, biopharma, clinical research, and sequencing infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize platforms that connect sample preparation, sequencing, bioinformatics, and interpretation in reproducible, auditable workflows. Investment decisions should favor technologies that improve sensitivity, throughput, spatial resolution, transcript isoform detection, and compatibility with degraded or low-input samples, especially formalin-fixed paraffin-embedded tissue used in translational oncology and pathology-linked research.

Organizations should build AI governance into product development, including dataset documentation, model validation, auditability, bias monitoring, privacy safeguards, and human-in-the-loop review. Partnerships with hospitals, biobanks, pharmaceutical sponsors, cloud infrastructure providers, regulatory experts, and academic consortia can accelerate clinical evidence generation, while workforce training in computational biology, molecular pathology, bioinformatics, and data engineering will remain essential for scalable adoption.

Research Methodology

The research methodology applies a triangulated approach combining peer-reviewed scientific literature, public genomic data repositories, clinical trial registries, regulatory guidance, funding announcements, patent activity, public health resources, and technology adoption indicators. The analysis emphasizes verified evidence from recognized scientific, regulatory, and institutional sources rather than unsupported commercial claims.

Segmentation is assessed across technology type, workflow, application, end user, and geography. Findings are validated through consistency checks across scientific adoption trends, translational research activity, regulatory developments, infrastructure availability, and regional research capacity, ensuring that conclusions reflect observable transcriptomics technology dynamics without relying on market sizing, share estimates, or forecasts.

Conclusion

Transcriptomics technologies are moving from exploratory research tools to foundational infrastructure for precision medicine, drug discovery, molecular diagnostics, and biological systems analysis. Momentum is supported by lower sequencing barriers, rising use of single-cell and spatial methods, improved long-read RNA analysis, stronger cloud bioinformatics, and demand for clinically meaningful RNA-based biomarkers.

The next phase of competition will be defined by integrated workflows, AI-enabled interpretation, data quality, regulatory readiness, interoperability, and regional access to advanced sequencing capabilities. Organizations that combine scientific rigor with scalable operations, transparent analytics, and clinically relevant evidence will be best positioned to capture value in the global transcriptomics technologies landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Transcriptomics Technologies Market, by Technology Type

  • 7.1. Bulk Transcriptomics
  • 7.2. Single-Cell Transcriptomics
  • 7.3. Spatial Transcriptomics
  • 7.4. Spatially Resolved Single-Cell Technologies

8. Transcriptomics Technologies Market, by Experimental Method

  • 8.1. Sequencing-Based Technologies
  • 8.2. Probe-Based Technologies
  • 8.3. Imaging-Based Technologies
  • 8.4. Array-Based Technologies

9. Transcriptomics Technologies Market, by Resolution Level

  • 9.1. Bulk Resolution
  • 9.2. Single-Cell Resolution
  • 9.3. Subcellular Resolution

10. Transcriptomics Technologies Market, by Data Output Type

  • 10.1. Whole Transcriptome Profiling
  • 10.2. Targeted Transcriptomics
  • 10.3. Multi-Omics Integrated Transcriptomics

11. Transcriptomics Technologies Market, by Application

  • 11.1. Oncology
  • 11.2. Neurology
  • 11.3. Immunology
  • 11.4. Developmental Biology
  • 11.5. Drug Discovery

12. Transcriptomics Technologies Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Transcriptomics Technologies Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Transcriptomics Technologies Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. 10x Genomics
  • 16.2. Agilent Technologies, Inc.
  • 16.3. Akoya Biosciences, Inc.
  • 16.4. BGI Genomics Co., Ltd.
  • 16.5. Bio-Rad Laboratories, Inc.
  • 16.6. Bio-Techne Corporation
  • 16.7. Dovetail Genomics
  • 16.8. F. Hoffmann-La Roche Ltd.
  • 16.9. Genomics England ecosystem partners
  • 16.10. Illumina, Inc.
  • 16.11. Mission Bio Inc.
  • 16.12. NanoString Technologies
  • 16.13. Novogene Corporation
  • 16.14. Oxford Nanopore Technologies plc
  • 16.15. Pacific Biosciences of California, Inc.
  • 16.16. Parse Biosciences
  • 16.17. QIAGEN N.V.
  • 16.18. SeqWell Inc.
  • 16.19. Singleron Biotechnologies
  • 16.20. Standard BioTools Inc.
  • 16.21. Takara Bio Inc.
  • 16.22. Thermo Fisher Scientific Inc.
  • 16.23. Ultivue Inc.
  • 16.24. Vizgen Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BULK TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SINGLE-CELL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SINGLE-CELL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SINGLE-CELL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPATIAL TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPATIALLY RESOLVED SINGLE-CELL TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPATIALLY RESOLVED SINGLE-CELL TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPATIALLY RESOLVED SINGLE-CELL TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SEQUENCING-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SEQUENCING-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SEQUENCING-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PROBE-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PROBE-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROBE-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IMAGING-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMAGING-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IMAGING-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARRAY-BASED TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARRAY-BASED TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARRAY-BASED TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BULK RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BULK RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BULK RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SINGLE-CELL RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SINGLE-CELL RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SINGLE-CELL RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUBCELLULAR RESOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SUBCELLULAR RESOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUBCELLULAR RESOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WHOLE TRANSCRIPTOME PROFILING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WHOLE TRANSCRIPTOME PROFILING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WHOLE TRANSCRIPTOME PROFILING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TARGETED TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TARGETED TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TARGETED TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MULTI-OMICS INTEGRATED TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MULTI-OMICS INTEGRATED TRANSCRIPTOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MULTI-OMICS INTEGRATED TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DEVELOPMENTAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 111. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 112. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. GCC TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 129. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 130. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. G7 TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 135. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 136. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. NATO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 148. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 149. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. CANADA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 154. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 155. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MEXICO TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 160. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 161. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. BRAZIL TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED KINGDOM TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 173. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GERMANY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 178. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 179. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. FRANCE TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 184. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 185. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. RUSSIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 190. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 191. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ITALY TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 197. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. SPAIN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 208. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 209. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. INDIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 214. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 215. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. JAPAN TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 220. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 221. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. AUSTRALIA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY EXPERIMENTAL METHOD, 2018-2032 (USD MILLION)
  • TABLE 226. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY RESOLUTION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 227. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY DATA OUTPUT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. SOUTH KOREA TRANSCRIPTOMICS TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)